We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Upgraded Hydrogel Stimulates Growth of New Blood Vessels for Tissue Regeneration

By LabMedica International staff writers
Posted on 03 Feb 2015
Print article
Image: The micrograph shows the extensive infiltration of robust blood vessels (red) in a new hydrogel scaffold developed to help the healing of internal injuries. The purple cells are pericyte-like cells that surround new endothelial cells, helping to stabilize the vessels. The green cells are circulating through the new vascular system (Photo courtesy of Dr. Vivek Kumar, Rice University).
Image: The micrograph shows the extensive infiltration of robust blood vessels (red) in a new hydrogel scaffold developed to help the healing of internal injuries. The purple cells are pericyte-like cells that surround new endothelial cells, helping to stabilize the vessels. The green cells are circulating through the new vascular system (Photo courtesy of Dr. Vivek Kumar, Rice University).
An upgraded hydrogel for in vivo use as scaffolding for cellular growth incorporates features that overcome most of the limitations that has precluded use of this type of material up to now.

Major limitations of current tissue regeneration approaches using artificial scaffolds are (1) fibrous encapsulation, (2) lack of host cellular infiltration, (3) unwanted immune responses, (4) surface degradation preceding biointegration, and (5) artificial degradation byproducts. Specifically, for scaffolds larger than 200–500 micrometers, implants must be accompanied by generation of new blood vessels by the host (angiogenesis) in order to provide adequate nutrient/waste exchange in the newly forming tissue.

Investigators at Rice University (Houston, TX, USA) reported in the January 13, 2015, online edition of the journal ACS Nano that they had designed a peptide-based self-assembling nano-fibrous hydrogel containing cell-mediated degradation and pro-angiogenic constituents that specifically addressed the limitations of earlier hydrogels. This hydrogel could be easily delivered by syringe, was rapidly infiltrated by cells of hematopoietic and mesenchymal origin, and rapidly formed an extremely robust mature vascular network. Scaffolds showed no signs of fibrous encapsulation and after three weeks were resorbed into the native tissue.

"Implanted synthetic materials tended to become encapsulated by fibrous barriers that kept cells and blood vessels from infiltrating the scaffold," said senior author Dr. Jeffrey Hartgerink, professor of chemistry at Rice University. "That is an extremely common problem in synthetic materials put into the body. Some avoid this problem but if the body does not like a material and is not able to destroy it, the solution is to wall it off. As soon as that happens, the flow of nutrients across that barrier decreases to almost nothing. So the fact that we have developed syringe-directed delivery of a material that does not develop fibrous encapsulation is really important."

"One thing that differentiates our work is the quality of the blood vessels that are formed," said Dr. Hartgerink. "In a lot of the published literature, you see rings that only have the endothelial cell lining, and that indicates a very immature blood vessel. These types of vessels usually do not persist, and disappear shortly after they show up. In ours, you see that same endothelial cell layer, but surrounding it is a smooth muscle cell layer that indicates a much more mature vessel that is likely to persist. There are a lot of features about this hydrogel that come together to make it a unique system. If you look through the literature at what other people have done, each concept that is involved in our system probably exists somewhere already. The difference is that we have all these features in one place working together."

Related Links:

Rice University 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The QIAstat-Dx Respiratory Panel Plus has received U.S. FDA clearance (Photo courtesy of QIAGEN)

New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results

Respiratory tract infections are a major reason for emergency department visits and hospitalizations. According to the CDC, the U.S. sees up to 41 million influenza cases annually, resulting in several... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more